×
For best experience we recommend to activate Javascript in your browser.
LRRC32 antibody (AA 162-405)
The Rabbit Polyclonal anti-LRRC32 antibody has been validated for WB, IHC, IP and ICC. It is suitable to detect LRRC32 in samples from Rat.
Quick Overview for LRRC32 antibody (AA 162-405) (ABIN7621538)
Target
See all LRRC32 Antibodies
LRRC32
(Leucine Rich Repeat Containing 32 (LRRC32))
Reactivity
All reactivities for LRRC32 antibodies
Rat
Host
All hosts for LRRC32 antibodies
Rabbit
Clonality
All clonalities for LRRC32 antibodies
Polyclonal
Conjugate
All conjugates for LRRC32 antibodies
This LRRC32 antibody is un-conjugated
Application
All applications for LRRC32 antibodies
Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
Product Details anti-LRRC32 Antibody
(hide)
Binding Specificity
All epitopes for LRRC32 antibodies
AA 162-405
Purpose
Leucine Rich Repeat Containing Protein 32 (LRRC32) Polyclonal Antibody
Sequence
Leu162~Tyr405
Characteristics
The Leucine Rich Repeat Containing Protein 32 (LRRC32) Polyclonal Antibody (Species: Rat) has been validated for the following applications: WB, IHC, ICC, IP.
Purification
Antigen-specific affinity chromatography followed by Protein A affinity chromatography
Alternatives
(show)
Application Details
(hide)
Application Notes
Optimal working dilution should be determined by the investigator.
Restrictions
For Research Use only
Handling
(hide)
Format
Liquid
Concentration
0.5 mg/mL
Buffer
PBS, pH 7.4, containing 0.02 % Sodium azide, 50 % glycerol
Preservative
Sodium azide
Precaution of Use
This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
Storage
4 °C,-20 °C
Storage Comment
2°C to 8°C for frequent use, -20°C for 12 months. Avoid repeated freeze/thaw cycles.
Expiry Date
12 months
Target Details for LRRC32
(hide)
Target
LRRC32
(Leucine Rich Repeat Containing 32 (LRRC32))
Alternative Name
LRRC32
Gene ID
293135
UniProt
D3ZVD5
Pathways
Activated T Cell Proliferation
Recently viewed
(hide)
Chat with us , powered by LiveChat